RDHL - RedHill Biopharma Ltd

Healthcare - Sector
Coverage Rating Distribution Performance Price Targets & Ratings Chart

RDHL is currently covered by 1 analysts with average potential upside of $8.45 (82.12%) backed by 9 price targets and 10 ratings. Documented since 14-Mar-2013.

Most recent stock forecast was given by SCOTT HENRY from ROTH on 26-Aug-2021.

Highest price target for RDHL is 7, Lowest price target is 7, average price target is 7.

Best performing analysts who are covering RDHL - RedHill Biopharma Ltd:

Scott Henry Stephen Brozak

Currently, out of the existing stock ratings of RDHL - 1 which are a Buy (100%)

Analyst name

Rating

Current price target

Potential distance

Previous price target

Date

Price targets met ratio

Average potential upside

Average time for PT to be met

Performance score

Buy

12

$7.56 (170.27%)

12

1 years 7 months 5 days ago

0/6 (0%)

$8.9 (75.35%)

Buy

17

3 years 8 months 19 days ago

0/1 (0%)

$8 (88.89%)

Show more analysts

What is RDHL(RedHill Biopharma Ltd) average time for price targets to be met?

On average it took 0 days on average for the stock forecasts to be realized with a an average price target met ratio 0

Which analyst has the current highest performing score on RDHL(RedHill Biopharma Ltd) with a proven track record?

SCOTT HENRY